When dealing with osteoarthritis, there are many treatment options that patients can consider taking in order to manage their symptoms. Arcoxia is one option. This drug belongs to a group of medicines ...

Merck today withdrew its application with the Food and Drug Administration for Arcoxia, its next-generation painkiller. Many analysts had been expecting the drug to help Merck win a long-standing duel ...

A Food & Drug Administration advisory panel last week recommended that Arcoxia, Merck's successor to the recalled Vioxx, not be approved for sale in the U.S. In a vote of 20 to 1, the panel said they ...

A pair of prominent heart experts said in a published report Thursday that studies of Merck’s COX-2 selective inhibitor Arcoxia revealed risks that make it unacceptable for approval in the US and that ...

The FDA gave painkiller Arcoxia, Merck's successor to Vioxx, the thumbs down today. The decision was expected, given the 20-1 vote against the drug by a committee of experts earlier this month. But ...

TRENTON, N.J. — The Food and Drug Administration rejected Merck & Co.’s request to market a successor to its withdrawn arthritis drug Vioxx in the U.S., the drug maker said Friday. The decision was ...

Merck's new pain reliever drug Arcoxia, which was proposed as a successor to Vioxx, was rejected by a federal health advisory panel. The news came out just after the market closed. Merck shares fell ...

Merck released outcomes data on experimental COX-2 drug Arcoxia, prompting mixed reviews including some from doctors who said the results do not support approval.Arcoxia (etoricoxib), a cox-2 drug ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

CHICAGO, Nov. 13 (UPI) -- U.S. firm Merck said Monday its new COX 2 painkiller -- in the same class as Vioxx -- has a cardiac risk similar to Novartis' Voltaren. According to data from a large patient ...

Merck has released data indicating that Arcoxia performed better than the generic diclofenac in treating arthritis. The data suggests that Arcoxia was no more dangerous than the older drug diclofenac ...